Back to resultsAntiemetic Effect of the Addition of Ondansetron to the Morphine Solution in Patient-Controlled Analgesia (PCA)
Primary Purpose
Postoperative Nausea and Vomiting
Status
Completed
Phase
Not Applicable
Locations
Thailand
Study Type
Interventional
Intervention
ondansetron adding in PCA
Sponsored by
About this trial
This is an interventional treatment trial for Postoperative Nausea and Vomiting focused on measuring ondansetron, PCA
Eligibility Criteria
Inclusion Criteria: Age between 15-60 years old Exclusion Criteria: History of motion sickness, smoking
Sites / Locations
- Khon Kaen university, Srinagarind Hospital
Outcomes
Primary Outcome Measures
PONV
Secondary Outcome Measures
Full Information
NCT ID
NCT00199329
First Posted
September 14, 2005
Last Updated
March 19, 2018
Sponsor
Khon Kaen University
1. Study Identification
Unique Protocol Identification Number
NCT00199329
Brief Title
Antiemetic Effect of the Addition of Ondansetron to the Morphine Solution in Patient-Controlled Analgesia (PCA)
Study Type
Interventional
2. Study Status
Record Verification Date
October 2007
Overall Recruitment Status
Completed
Study Start Date
January 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Khon Kaen University
4. Oversight
5. Study Description
Brief Summary
PCA morphine always introduces nausea and vomiting during the postoperative period. Ondansetron can reduce PONV (postoperative nausea vomiting). We, the researchers at Khon Kaen University, are trying to add ondansetron in PCA morphine. Patients receive a small dose of ondansetron when they request morphine.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Nausea and Vomiting
Keywords
ondansetron, PCA
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
160 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
ondansetron adding in PCA
Primary Outcome Measure Information:
Title
PONV
Time Frame
24 hr
10. Eligibility
Sex
All
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age between 15-60 years old
Exclusion Criteria:
History of motion sickness, smoking
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Polpun Boonmak, MD
Organizational Affiliation
lecturer in Khon Kaen University
Official's Role
Study Director
Facility Information:
Facility Name
Khon Kaen university, Srinagarind Hospital
City
Muang
State/Province
Khon Kaen
ZIP/Postal Code
40002
Country
Thailand
12. IPD Sharing Statement
Learn more about this trial
Antiemetic Effect of the Addition of Ondansetron to the Morphine Solution in Patient-Controlled Analgesia (PCA)
We'll reach out to this number within 24 hrs